OOIR: Observatory of International Research

Papers

(The median citation count of Annual Review of Medicine is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Normal Gut Microbiomes in Diverse Populations: Clinical Implications	510
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines	389
COVID-19 Vaccines: Adenoviral Vectors	246
Clinical Phenotypes of Cystic Fibrosis Carriers	235
Carbon Monoxide Poisoning: From Microbes to Therapeutics	192
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic Complication	145
Treatments for COVID-19	145
Clonal Expansion of Stem/Progenitor Cells in Cancer, Fibrotic Diseases, and Atherosclerosis, and CD47 Protection of Pathogenic Cells	135
New Biological Therapies for Multiple Myeloma	125
Gender-Affirming Care of Transgender and Gender-Diverse Youth: Current Concepts	121
Care Models for Cancer Survivors	119
New Therapeutic Approaches to Large-Vessel Vasculitis	112
Multispecific CAR T Cells Deprive Lymphomas of Escape via Antigen Loss	100
Club Cell Secretory Protein in Lung Disease: Emerging Concepts and Potential Therapeutics	100
Health Effects of Wildfire Smoke Exposure	96
Cystic Fibrosis Modulator Therapies	83
Exercise in Octogenarians: How Much Is Too Little?	81
Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection	80
Advances in Therapy for Refractory Epilepsy	80
Precision Approaches to Chronic Obstructive Pulmonary Disease Management	79
Spontaneous Coronary Artery Dissection: New Insights into This Not-So-Rare Condition	77
Application and Expectations for Immune Checkpoint Blockade of LAG3 and TIGIT	68
MELD 3.0 in Advanced Chronic Liver Disease	67
Phage Therapy for Antibiotic-Resistant Bacterial Infections	65
COVID-19 and Kidney Disease	60

Clinical Perspectives on IgG4-Related Disease and Its Classification	60
Sleep Health Disparities	58
Genetics of Dilated Cardiomyopathy	57
Myocardial Infarction with Nonobstructive Coronary Arteries	50
The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies	50
Update in Adult Transgender Medicine	48
RASopathies in Cardiac Disease	45
	44
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment	43
SGLT2 Inhibitors: The Sweet Success for Kidneys	43
Update on the Porphyrias	41
The Hospitalist Movement 25 Years Later	41
Update on Hepatorenal Syndrome: From Pathophysiology to Treatment	39
Approach to Therapy for Chronic Pouchitis	39
Endocrine Disorders and COVID-19	37
Candida auris: Epidemiology and Antifungal Strategy	36
Effects on Cancer Prevention from the COVID-19 Pandemic	35
Emerging Technologies in Cardiac Pacing	35
COVID-19 and Diabetes	34
Progress in the Management of Pancreatic Neuroendocrine Tumors	33
A Rational Approach to the Treatment of Acute Pulmonary Embolism	30
A Tale of Two Checkpoints: ATR Inhibition and PD-(L)1 Blockade	30
Update on HIV Chemoprevention	29
Adverse Impact of Cannabis on Human Health	29
Advances and Applications of Polygenic Scores for Coronary Artery Disease	28
	27
COVID-19 Thrombotic Complications and Therapeutic Strategies	27
Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys	27
Interventional Pulmonology: Extending the Breadth of Thoracic Care	27
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies	27
Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome	27
COVID-19: Inflammatory Profile	26
Wearable Devices: Implications for Precision Medicine and the Future of Health Care	25
Clonal Hematopoiesis and Its Impact on Human Health	25
What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?	24
COVID-19 Critical Illness: A Data-Driven Review	23
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics	23
Maternal Mortality in the United States: Trends and Opportunities for Prevention	22
Medical Therapy Alone, Percutaneous Coronary Intervention, or Coronary Artery Bypass Grafting for Treatment of Coronary Artery Disease	22
New Oral Selective Estrogen Receptor Degraders Redefine Management of Estrogen Receptor–Positive Breast Cancer	22
Subclinical Atrial Fibrillation: A Silent Threat with Uncertain Implications	21
Long-Term Risks of Living Kidney Donation: State of the Evidence and Strategies to Resolve Knowledge Gaps	20
Chronic Neuromuscular Respiratory Failure and Home Assisted Ventilation	20
Cytomegalovirus Therapy: Role of Letermovir in Prophylaxis and Treatment in Transplant Recipients	19
Exome/Genome Sequencing in Undiagnosed Syndromes	18
Treatment of Delirium During Critical Illness	17
Fatty Liver Disease: Diagnosis and Stratification	17